Sino Biological Inc
SZSE:301047
Intrinsic Value
Sino Biological Inc. provides protein, antibody and gene products. [ Read More ]
The intrinsic value of one
Sino Biological Inc
stock under the Base Case scenario is
54.28
CNY.
Compared to the current market price of 75.45 CNY,
Sino Biological Inc
is
Overvalued by 28%.
Sino Biological Inc's market price has consistently been higher than its intrinsic value.This persistent overvaluation suggests the market may be overly optimistic about
Sino Biological Inc or that its price is influenced by factors unrelated to fundamentals.
Sino Biological Inc's market capitalization is 9.7B CNY.
Sino Biological Inc stock price is 75.45 CNY.
Sino Biological Inc stock (54.28 CNY) is 28% less than its price (75.45 CNY).
Sino Biological Inc stock (61.91 CNY) is 18% less than its price (75.45 CNY). Open DCF Valuation
Sino Biological Inc stock (46.65 CNY) is 38% less than its price (75.45 CNY). Open Relative Valuation
Sino Biological Inc has upside potential of 39% compared to the average analyst price target.
Open Wall St Estimates
Sino Biological Inc's ROIC (Return on Invested Capital) for the past 12 months is positive and is equal to 8%.
Sino Biological Inc's Revenue has grown by 15% over the past 12 months.
Sino Biological Inc's ROE (Return on Equity) for the past 12 months is very low and is equal to 3%.
Sino Biological Inc has positive three-year average ROE (Return on Equity): 18%. The company is efficient at transforming stockholders' equity into net income.
Sino Biological Inc's ROE (Return on Equity) has significantly decreased in the last 3 years from 86% to 3%.
Sino Biological Inc's ROIC (Return on Invested Capital) has significantly decreased in the last 3 years from 377% to 8%.
Sino Biological Inc has negative Free Cash Flow for the last twelve months.
Sino Biological Inc has positive Operating Income for the last twelve months.
Sino Biological Inc has positive Net Income for the last twelve months.
Sino Biological Inc has positive Gross Profit for the last twelve months.
Sino Biological Inc's Revenue has been falling by 31% per year for the last 3 years.
Sino Biological Inc's D/E (Debt to Equity) is very low and is equal to 0.01.
Sino Biological Inc has very high three-year average ROIC (Return on Invested Capital): 136%. The company is very efficient at using invested capital to generate operating income.
Sino Biological Inc's short-term assets (5B CNY) exceed its short-term liabilties (136m CNY).
Sino Biological Inc's long-term assets (7B CNY) exceed its long-term liabilties (234m CNY).
Sino Biological Inc has negative Net Debt. This means that the company has more cash and short-term investments (5B CNY) than debt (62m CNY).
Sino Biological Inc's Altman Z-Score is very high and is equal to 23.97.
Valuation Backtest
Sino Biological Inc
Run backtest to discover the historical profit from buying and selling
Sino Biological Inc
stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Sino Biological Inc
Balance Sheet Decomposition
Sino Biological Inc
| Current Assets | 5.1B |
| Cash & Short-Term Investments | 4.8B |
| Receivables | 133.5m |
| Other Current Assets | 115.3m |
| Non-Current Assets | 1.5B |
| Long-Term Investments | 450.1m |
| PP&E | 916.4m |
| Intangibles | 799.4k |
| Other Non-Current Assets | 164.4m |
| Current Liabilities | 136.4m |
| Accounts Payable | 19.3m |
| Accrued Liabilities | 55.4m |
| Other Current Liabilities | 61.7m |
| Non-Current Liabilities | 97.3m |
| Long-Term Debt | 61.7m |
| Other Non-Current Liabilities | 35.6m |
Earnings Waterfall
Sino Biological Inc
|
Revenue
|
641.7m
CNY
|
|
Cost of Revenue
|
-133m
CNY
|
|
Gross Profit
|
508.7m
CNY
|
|
Operating Expenses
|
-392.6m
CNY
|
|
Operating Income
|
116.1m
CNY
|
|
Other Expenses
|
104.1m
CNY
|
|
Net Income
|
220.2m
CNY
|
Free Cash Flow Analysis
Sino Biological Inc
Profitability Score
Profitability Due Diligence
Sino Biological Inc's profitability score is 56/100. The higher the profitability score, the more profitable the company is.
Score
Sino Biological Inc's profitability score is 56/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Sino Biological Inc's solvency score is 87/100. The higher the solvency score, the more solvent the company is.
Score
Sino Biological Inc's solvency score is 87/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Sino Biological Inc
According to Wall Street analysts, the average 1-year price target for
Sino Biological Inc
is 104.55 CNY
with a low forecast of 103.02 CNY and a high forecast of 108.15 CNY.
Shareholder Return
Price
Sino Biological Inc
| Average Annual Return | -35.2% |
| Standard Deviation of Annual Returns | 10.86% |
| Max Drawdown | -80% |
| Market Capitalization | 9.7B CNY |
| Shares Outstanding | 129 200 000 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
Sino Biological Inc
Country
Industry
Market Cap
Dividend Yield
Description
Sino Biological Inc. provides protein, antibody and gene products. The company is headquartered in Beijing, Beijing and currently employs 495 full-time employees. The company went IPO on 2021-08-16. The firm's main business includes products such as recombinant proteins, antibodies, genes and culture media, as well as the development of recombinant proteins and antibodies, and biological analysis and testing services. The firm operates in the domestic market and overseas markets.
Contact
IPO
Employees
Officers
The intrinsic value of one
Sino Biological Inc
stock under the Base Case scenario is
54.28
CNY.
Compared to the current market price of 75.45 CNY,
Sino Biological Inc
is
Overvalued by 28%.
You don't have any saved screeners yet
